Huyen Tran

Projects

Projects per year 2010 2019 2020 2023 2026

• 7 Finished
• 26 Active

Projects per year

Search results

• Active

  A phase 2 study to evaluate the efficacy and safety of ianalumab (VAY736) in patients with primary immune thrombocytopenia (ITP) previously treated with at least a corticosteroid and a thrombopoietin receptor agonist (TPO-RA)

  Tran, H. & Malherbe, M.

  8/09/23 → 7/09/25

  Project: Research

• A Global, Open-label Study to Investigate the Efficacy and Safety of SerpinPC in Subjects With Hemophilia B With Inhibitors

  Tran, H. & Malherbe, M.

  3/09/23 → 2/09/25

  Project: Research

• A phase 3, randomized, double-blind, study to assess efficacy and safety of ianalumab (VAY736) versus placebo in warm autoimmune hemolytic anemia (wAIHA) patients who failed at least one line of treatment (VAYHIA)

  Tran, H. & Kennedy, N.

  3/03/23 → 3/03/25

  Project: Research

• A phase III, randomized, double-blind study of ianalumab (VAY736) versus placebo in addition to first-line corticosteroids in primary immune thrombocytopenia (VAYHIT1)

  Tran, H., Kennedy, N. & Young-Ill Choi, P.

  14/02/23 → 14/02/25

  Project: Research

• A multicenter, randomized, open-label, blinded endpoint evaluation, phase 3 study comparing the effect of abelacimab relative to apixaban on venous thromboembolism (VTE) recurrence and bleeding in patients with cancer associated VTE (ASTER)

  Tran, H. & Kennedy, N.

  20/01/23 → 19/01/25

  Project: Research

• A multicenter, randomized, open-label, blinded endpoint evaluation, phase 3 study comparing the effect of abelacimab relative to dalteparin on venous thromboembolism (VTE) recurrence and bleeding in patients with gastrointestinal (GI)/genitourinary (GU) cancer associated VTE (Magnolia)

  Tran, H. & Kennedy, N.

  20/01/23 → 19/01/25

  Project: Research

• A Multi-Center Evaluation of the Long-Term Safety and Efficacy of Spark-sponsored Gene Therapies In Males with Hemophilia A

  Tran, H. & Malherbe, M.

  3/11/22 → 3/11/26

  Project: Research

• AN INTERVENTIONAL PHASE 2, OPEN-LABEL, MULTI CENTER STUDY TO EVALUATE SAFETY AND EFFICACY OF PF-06835375 IN ADULT PARTICIPANTS WITH MODERATE TO SEVERE PRIMARY IMMUNE THROMBOCYTOPENIA

  Tran, H., Leahy, M. F. & Kennedy, N.

  17/05/22 → 31/12/24

  Project: Research

• A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase III Study with a Long-Term, Open-label Extension to Evaluate the Efficacy and Safety of TRM-201 (Rofecoxib) in Patients with Hemophilic Arthropathy

  Tran, H. & Kennedy, N.

  11/05/22 → 10/05/24

  Project: Research

• A Phase 2, Open-Label, Repeat-Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Proof-of-Concept of Intravenous ANX005 in Subjects with Warm Autoimmune Hemolytic Anemia.

  Tran, H. & Kennedy, N.

  14/02/22 → 31/12/23

  Project: Research

• A Study to Evaluate the Complement Signature of Subjects with Warm Autoimmune Hemolytic Anemia.

  Tran, H., Szer, J. & Kennedy, N.

  3/11/21 → 31/12/24

  Project: Research

• A national, multi-centre study evaluating Thrombotic Thrombocytopenia Syndrome (TTS) associated with ChAdOx1 (AZD1222) and other SARS-CoV-2 vaccines (viral vector and m-RNA)

  Tran, H., Chen, V., Chunilal, S., Wood, N. J., Phan, T., Buttery, J., Crawford, N. W., Monagle, P. T., Passam, F., McFadyen, J., Whisstock, J., McRae, S., Pepperell, D., Tan, C. W., Bird, R. J., Járai-Szabó, F., Kleinig, T. J. & Wood, E.

  Department of Health and Aged Care (Australia)

  1/11/21 → 31/10/24

  Project: Research

• A Phase 3b, Single Arm, Open-label Study to Evaluate the Efficacy and Safety of BMN 270, an Adeno-Associated Virus Vector-Mediated Gene Transfer of Human Factor VIII, with Prophylactic Corticosteroids in Hemophilia A Patients.

  Tran, H. & Kennedy, N.

  2/12/20 → 31/12/25

  Project: Research

• An Open-Label Study in Adolescent and Adult Severe (Coagulation Factor Activity <1%) Hemophilia A or B Patients With or Without Inhibitors Comparing Standard Treatment to PF-06741086 Prophylaxis.

  Tran, H. & Kennedy, N.

  6/10/20 → 31/12/25

  Project: Research

• A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (C-935788-058).

  Tran, H. & Kennedy, N.

  31/03/20 → 31/12/25

  Project: Research

• Screening and Lead-in Observational Protocol to Determine Potential Patient Eligibility for Inclusion in AAV Gene Therapy Clinical Trials in Haemophlia B (ECLIPSE)

  Tran, H. & Kennedy, N.

  20/02/20 → 31/12/25

  Project: Research

• Gene-transfer, open-label, dose escalation study of SPK-8011 [adeno-associated viral vector with B-domain-deleted human factor VIII gene] in individuals with haemophilia A

  Tran, H. & Kennedy, N.

  14/02/20 → 31/12/25

  Project: Research

• A Phase 1b, Multi-center, Randomized, Double blind, Placebo-controlled Study to Investigate the Efficacy, Safety and Pharmacokinetics of CSL312 in the Prevention of Peripherally Inserted Central Catheter (PICC)-associated Thrombosis in Subjects with Cancer

  Tran, H., Chunilal, S., Casey, J., Sanmugarajah, J. & Kennedy, N.

  10/02/20 → 31/12/25

  Project: Research

• COBRRA: Apixaban Twice Daily vs Rivaroxaban Once Daily for the Treatment of Venous Thromboembolism: A randomised controlled trial

  Chen, V., Castellucci, L., Brighton, T. A., Tran, H., Rodger, M., Le Gal, G., Kahn, S., Simes, R. J., Reddel, C. & Morton, R. L.

  1/02/20 → 31/01/24

  Project: Research

• Efficacy and Safety of Concizumab prophylaxis in patients with haemophilia A or B without inhibitors (Explorer8)

  Tran, H. & Kennedy, N.

  20/01/20 → 31/12/25

  Project: Research

• Efficacy and Safety of Concizumab prophylaxis in patients with haemophilia A or B with inhibitors (Explorer7).

  Tran, H. & Kennedy, N.

  20/01/20 → 31/12/25

  Project: Research

• A Phase 3 Open-Label, Single-Arm Study to Evaluate The Efficacy and Safety of BMN 270, an Adeno-Associated Virus Vector-Mediated Gene Transfer of Human Factor VIII in Hemophilia A patients with Residual FVIII Levels < 1 IU/dL Receiving Prophylactic FVIII Infusions.

  Tran, H. & Kennedy, N.

  1/10/19 → 31/12/24

  Project: Research

• A Phase 3, Mutli-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia.

  Tran, H. & Kennedy, N.

  15/08/19 → 31/12/24

  Project: Research

• ATLAS-OLE: An Open-label, Long-term Safety and Efficacy Study of Fitusiran in Patients with Hemophilia A or B, with or without Inhibitory Antibodies to Factor VIII or IX.

  Tran, H. & Kennedy, N.

  20/05/19 → 31/12/24

  Project: Research

• A Multi-Center, Observational Study in Males with Hemophilia A.

  Tran, H. & Kennedy, N.

  21/03/19 → 31/12/24

  Project: Research

• A Prospective Non-Interventional Study of Bleeding Episodes, Factor VIII Infusions, and Patient-Reported Outcomes in Individuals with Severe Hemophilia A.

  Tran, H. & Kennedy, N.

  10/01/19 → 31/12/24

  Project: Research